AT197965B - Verfahren zur Herstellung von Insulinpräparaten mit protrahierter Wirkung - Google Patents
Verfahren zur Herstellung von Insulinpräparaten mit protrahierter WirkungInfo
- Publication number
- AT197965B AT197965B AT197965DA AT197965B AT 197965 B AT197965 B AT 197965B AT 197965D A AT197965D A AT 197965DA AT 197965 B AT197965 B AT 197965B
- Authority
- AT
- Austria
- Prior art keywords
- manufacture
- insulin preparations
- protracted action
- protracted
- action
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK197965X | 1951-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT197965B true AT197965B (de) | 1958-05-27 |
Family
ID=8149889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT197965D AT197965B (de) | 1951-03-06 | 1951-04-03 | Verfahren zur Herstellung von Insulinpräparaten mit protrahierter Wirkung |
Country Status (1)
| Country | Link |
|---|---|
| AT (1) | AT197965B (de) |
-
1951
- 1951-04-03 AT AT197965D patent/AT197965B/de active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH469769A (de) | Verfahren zur Herstellung von Polybenzoxazindionen | |
| AT175782B (de) | Verfahren zur Herstellung von Halbzellstoff | |
| CH314328A (de) | Verfahren zur Herstellung von Polyazofarbstoffen | |
| CH317464A (de) | Verfahren zur Herstellung von Polyazofarbstoffen | |
| CH310713A (de) | Verfahren zur Herstellung von p-Butylamino-benzoesäure-y-amino-B-oxy-propylester. | |
| AT197965B (de) | Verfahren zur Herstellung von Insulinpräparaten mit protrahierter Wirkung | |
| AT175895B (de) | Verfahren zur Herstellung von N1-heterocyclisch substituierten Benzolsulfonamiden | |
| AT172334B (de) | Verfahren zur Herstellung von N-Dialkylaminoalkylphenthiazinen | |
| AT176020B (de) | Verfahren zur Herstellung von modifizierten Polysiloxanen | |
| AT179289B (de) | Verfahren zur Herstellung von Halogenfluoräthenen | |
| AT172050B (de) | Verfahren zur Herstellung von N1-acylierten Aminoarylsulfonamiden | |
| AT173458B (de) | Verfahren zur Herstellung von 3-Pyridyl-carbinol | |
| AT177770B (de) | Verfahren zur Herstellung von Oxyphenylserinen | |
| CH316743A (de) | Verfahren zur Herstellung von Antidiazotaten | |
| AT181692B (de) | Verfahren zur Herstellung von zur Injektion bestimmten Präparaten | |
| AT173251B (de) | Verfahren zur Herstellung von Alkylarylsulfonaten | |
| CH305571A (de) | Verfahren zur Herstellung von Dibutolactam. | |
| AT178898B (de) | Verfahren zur Herstellung von Hexamethylentetramin | |
| AT195913B (de) | Verfahren zur Herstellung von reinstem N-Diäthylaminoacetxylidid-2,6 | |
| AT173695B (de) | Verfahren zur Herstellung von 3-Fluor-4-oxy-phenylessigsäure | |
| AT176949B (de) | Verfahren zur Herstellung wässeriger Lösungen von 4-Dimethylaminoantipyrin | |
| AT182197B (de) | Verfahren zur Herstellung stabiler Lösungen von Chloramphenicol für Injektionszwecke | |
| AT195573B (de) | Verfahren zur Herstellung von Penicillinpräparaten mit verbesserter Depotwirkung | |
| AT167859B (de) | Verfahren zur Herstellung von zur Schädlingsbekämpfung geeigneten Präparaten | |
| AT171712B (de) | Verfahren zur Herstellung von 5,5-Dimenthyl-3-alkyl-oxazolidin-2,4-dionen |